View Section: Price ratios
Roselabs Statements
53
Roselabs Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2024-03-31
%
11.778
100
11.253
96.3
0.436
3.7
—
0
0.187
1
0.882
4
-0.357
-0.3
—
0
—
0
-0.357
-0.3
—
0
-0.357
-0.3
-0.033
10.477
2023-09-30
%
—
100
—
0
—
0
—
0
0.275
0
0.963
0
-0.963
0
—
0
—
0
-0.963
0
—
0
-0.963
0
-0.09
10.705
2023-03-31
%
1.5
100
—
0
—
0
—
0
0.19
12.5
2.56
281.3
-1.05
-181.2
—
0
—
0
24.99
3073.7
0.47
0
24.52
3073.7
2.51
8.59
2022-09-30
%
—
100
—
0
—
0
—
0
0.31
0
4.36
0
-4.36
0
—
0
—
0
-4.36
0
—
0
-4.36
0
-0.44
9.59
2022-03-31
%
—
100
—
0
—
0
—
0
0.35
0
1.85
0
-1.85
0
—
0
—
0
-1.85
0
-0.01
0
-1.84
0
-0.18
10.395
2021-09-30
%
—
100
—
0
—
0
—
0
0.15
0
2.53
0
-2.53
0
—
0
—
0
-2.53
0
—
0
-2.53
0
-0.26
9.715
View Section: Balance Sheet